Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

Selective stock-picking and conviction drove HB Biotech’s strong 2024 performance. Read our insights on navigating today’s ...

A large new study has shed light on the wider health impacts of taking Ozempic-style drugs. Weight-loss drugs like Ozempic ...

GLP-1 drugs like Ozempic have swept the world as effective therapies for far more than their original target of diabetes.

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...

One of the world’s largest studies of Ozempic, Mounjaro and other blockbuster diabetes and obesity drugs highlighted their impact on the brain, pointing to benefits from addiction to schizophrenia.

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...

The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity Research. Current market leaders include Novo Nordisk NVO and Eli Lilly LLY with ...

Oren, Tal and Alon Alexander will be extradited from Miami to New York, where they will remain in federal detention until trial. The New York Times would like to help tell the stories of people ...

Trump will take the action against the so-called “Spies Who Lie” as part of a flurry of executive orders he’s expected to sign on his first day back in the Oval Office, Fox News reported ...